BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21771028)

  • 1. Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin.
    Stewart CJ; Crook ML; Manso L
    Histopathology; 2011 Jul; 59(1):73-80. PubMed ID: 21771028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-anatomical variation in cellular proliferation in endometrial adenocarcinoma, and inverse correlation between Ki67 and cytokeratin 7 expression.
    Stewart CJ; Crook ML; Doherty DA
    Histopathology; 2010 Jul; 57(1):46-54. PubMed ID: 20557372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial-mesenchymal transition.
    Stewart CJ; Little L
    Histopathology; 2009 Jul; 55(1):91-101. PubMed ID: 19614771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 expression in uterine endometrioid adenocarcinoma: comparison of staining in conventional tumor glands and in areas of MELF pattern myometrial invasion.
    Stewart CJ; Crook ML
    Int J Gynecol Pathol; 2010 Nov; 29(6):555-61. PubMed ID: 20881856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147 (EMMPRIN) and matrix metalloproteinase-2 expression in uterine endometrioid adenocarcinoma.
    Stewart CJ; Crook ML
    Pathol Res Pract; 2011 Jan; 207(1):30-6. PubMed ID: 21144675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium.
    Stewart CJ; Crook ML; Lacey J; Louwen K
    Int J Gynecol Pathol; 2011 Sep; 30(5):484-91. PubMed ID: 21804393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fascin expression in endocervical neoplasia: correlation with tumour morphology and growth pattern.
    Stewart CJ; Crook M; Loi S
    J Clin Pathol; 2012 Mar; 65(3):213-7. PubMed ID: 22128198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
    Murray SK; Young RH; Scully RE
    Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis.
    Hertel JD; Huettner PC; Pfeifer JD
    Int J Gynecol Pathol; 2014 Mar; 33(2):127-34. PubMed ID: 24487466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.
    Dogan Altunpulluk M; Kir G; Topal CS; Cetiner H; Gocmen A
    J Obstet Gynaecol; 2015 May; 35(4):397-402. PubMed ID: 25279582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
    Han G; Lim D; Leitao MM; Abu-Rustum NR; Soslow RA
    Histopathology; 2014 Feb; 64(3):389-98. PubMed ID: 24215212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion.
    Stewart CJ; Brennan BA; Leung YC; Little L
    Pathology; 2009; 41(5):454-9. PubMed ID: 19900084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of fascin expression in endometrioid carcinoma.
    Kabukcuoglu S; Oner U; Ozalp SS; Dundar E; Yalcin OT; Colak E
    Eur J Gynaecol Oncol; 2006; 27(5):481-6. PubMed ID: 17139983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS mutation and microsatellite instability in endometrial adenocarcinomas showing MELF-type myometrial invasion.
    Stewart CJ; Amanuel B; Grieu F; Carrello A; Iacopetta B
    J Clin Pathol; 2010 Jul; 63(7):604-8. PubMed ID: 20591910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microcystic, elongated and fragmented invasion pattern in endometrial carcinoma: the clinicopathology analysis].
    Zhang XB; Zhao CL; Qi XL; Qin Y; Wang Y; Shen DH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):811-815. PubMed ID: 30585018
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
    Quick CM; May T; Horowitz NS; Nucci MR
    Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance.
    Espinosa I; Serrat N; Zannoni GF; Rovira R; D'Angelo E; Prat J
    Hum Pathol; 2017 Dec; 70():6-13. PubMed ID: 28601659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands.
    Stewart CJ; Crook ML; Leung YC; Platten M
    Mod Pathol; 2009 May; 22(5):725-33. PubMed ID: 19270644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MELF invasion in endometrial cancer as a risk factor for lymph node metastasis.
    Pavlakis K; Messini I; Vrekoussis T; Panoskaltsis T; Chrysanthakis D; Yiannou P; Voulgaris Z
    Histopathology; 2011 May; 58(6):966-73. PubMed ID: 21438907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.